Fundz

Eikon Therapeutics reported raising $351 Million in an initial SEC Form D filing, from an offering of $400 Million

PUBLIC · EIKNFeb 28, 2025$350.7M of $400M raised

Amount Raised

$351 Million

$351 Million sold, per SEC Form D (first sale Feb 14, 2025)

Round Type

Venture

MillbraeBiotechnologyHealth CareTherapeutics

Investors

Soros CapitalGeneral CatalystForesite CapitalE15 VcColumn GroupAME Cloud VenturesAlexandria Venture Investments

Quick answer

Eikon Therapeutics raised $351 Million in a funding round, dated February 14, 2025. Investors: Soros Capital, General Catalyst, Foresite Capital, E15 Vc, Column Group, AME Cloud Ventures and Alexandria Venture Investments. Eikon Therapeutics is based in Millbrae, California, United States.

How much did Eikon Therapeutics raise?
Eikon Therapeutics raised $351 Million in a funding round on February 14, 2025.
Who invested in Eikon Therapeutics?
Soros Capital, General Catalyst, Foresite Capital, E15 Vc, Column Group, AME Cloud Ventures and Alexandria Venture Investments are named as investors in this round.
What does Eikon Therapeutics do?
Eikon Therapeutics is advancing breakthrough therapies through the purposeful integration of science and engineering.
Where is Eikon Therapeutics based and how big is it?
Eikon Therapeutics is based in Millbrae, California, United States. Fundz records about 390 employees.
Who are the decision-makers at Eikon Therapeutics?
Fundz holds 1 contact at Eikon Therapeutics, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Eikon Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • NewcelX raised $2M (Seed) on March 28, 2025.
  • Epicrispr Biotechnologies raised $68M (Series B) on March 27, 2025.
  • Surrozen raised $76M on March 26, 2025.
  • Tribune Therapeutics raised $40M (Seed) on March 26, 2025.
  • Hillstar Bio raised $67M (Series A) on March 25, 2025.
  • Tempero Bio raised $70M (Series B) on March 24, 2025.

Who to call at Eikon Therapeutics, and when

A new round usually means Eikon Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Eikon Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Eikon Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Eikon Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Eikon Therapeutics

Location

230 Harriet Tubman Way

Millbrae, California, United States

About

Eikon Therapeutics is advancing breakthrough therapies through the purposeful integration of science and engineering. Our proprietary discovery technologies leverage Nobel Prize-winning super-resolution microscopy, advanced engineering, and high-performance computing to visualize and measure the real-time movement of proteins in living cells, with the goal of bringing important new medicines to people suffering from grievous illness.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Eikon Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsBenjamin T., Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Eikon Therapeutics's next move

See what Strategic adds

Eikon Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.